Preclinical Drug Discovery Research and Training at Vanderbilt

Abstract

ADVERTISEMENT RETURN TO ISSUEPREVIn FocusNEXTPreclinical Drug Discovery Research and Training at VanderbiltCraig W. Lindsley†‡*, David Weaver†, Carrie Jones†, Larry Marnett†, and P. Jeffrey Conn†View Author Information† Vanderbilt Institute of Chemical Biology Program in Drug Discovery, Department of Pharmacology, Vanderbilt Medical Center, Nashville, Tennessee 37232‡ Department of Chemistry, Vanderbilt University, Nashville, Tennessee 37235*Corresponding author, [email protected]Cite this: ACS Chem. Biol. 2007, 2, 1, 17–20Publication Date (Web):January 19, 2007Publication History Received15 December 2006Accepted18 December 2006Published online19 January 2007Published inissue 1 January 2007https://doi.org/10.1021/cb6004867Copyright © 2007 American Chemical SocietyRIGHTS & PERMISSIONSArticle Views425Altmetric-Citations7LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InReddit Read OnlinePDF (262 KB) Get e-AlertsSUBJECTS:Assays,Cancer therapy,Drug discovery,Screening assays,Students Get e-Alerts